Mostrando 5 resultados de: 5
Filtros aplicados
Publisher
PLoS Neglected Tropical Diseases(2)
Acta Tropica(1)
Antimicrobial Agents and Chemotherapy(1)
Memorias do Instituto Oswaldo Cruz(1)
Área temáticas
Enfermedades(4)
Medicina forense; incidencia de enfermedades(3)
Farmacología y terapéutica(2)
Fisiología humana(1)
Medicina y salud(1)
Origen
scopus(5)
Chagas disease control-surveillance in the americas: The multinational initiatives and the practical impossibility of interrupting vector-borne trypanosoma cruzi transmission
ArticleAbstract: Chagas disease (CD) still imposes a heavy burden on most Latin American countries. Vector-borne andPalabras claves:Chagas disease, control, Interruption of transmission, Multinational initiatives, SurveillanceAutores:Fernando Abad-Franch, Guhl F., Monroy C., Rojas-De-Arias A., Santos W.S., Sosa-Estani S.Fuentes:scopusDevelopment of Peptide-Based Lineage-Specific Serology for Chronic Chagas Disease: Geographical and Clinical Distribution of Epitope Recognition
ArticleAbstract: Background:Chagas disease, caused by infection with the protozoan Trypanosoma cruzi, remains a serioPalabras claves:Autores:Bhattacharyya T., Carrasco H.J., Diosque P., Falconar A.K.I., García L., Guhl F., Jaime Alfredo Costales, Lewis M.D., Litvinov S.V., Luquetti A.O., Mario J. Grijalva, Messenger L.A., Miles M.A., Ramírez J.D., Tran T.T.Fuentes:scopusTowards a paradigm shift in the treatment of chronic chagas disease
ReviewAbstract: Treatment for Chagas disease with currently available medications is recommended universally only foPalabras claves:Autores:Araujo-Jorge T., de Noya B.A., Gascón J., Guhl F., López M.C., Mario J. Grijalva, Ramsey J.M., Ribeiro I., Schijman A.G., Sosa-Estani S., Torrico F., Viotti R.Fuentes:scopusSerological reactivity against T. cruzi-derived antigens: Evaluation of their suitability for the assessment of response to treatment in chronic Chagas disease.
ArticleAbstract: Chagas disease, caused by the protozoan Trypanosoma cruzi, affects more than 6 million people worldwPalabras claves:3973, antigens, Chagas disease, Chemotherapy response, Chronic infection, F29, hsp70, InfYnity multiplexed ELISA, KMP11, PFR2, TRYPANOSOMA CRUZIAutores:Abril M., Alonso-Padillaid J., Benítez C., Casellas A., Chatelain E., de Noya B.A., Esteva M., Gascón J., Gómez I., Granjon E., Guhl F., Hasslochermoreno A.M., Jorge T.A., Longhi S.A., López M.C., Luquetti A.O., Mario J. Grijalva, Méndez S., Noya O., Pinazo M.J., Ramsey J.M., Ribeiro I., Ruiz A.M., Sanz S., Schijman A.G., Sosa-Estani S., Thomas M.C., Torrico F., Viotti R., Zrein M.Fuentes:scopusTarget product profile for a test for the early assessment of treatment efficacy in chagas disease patients: An expert consensus
ArticleAbstract:Palabras claves:Autores:Abril M., Almeida I.C., Alonso-Padillaid J., Angheben A., Carmen Thomas M., Chatelain E., de Noya B.A., Esteva M., Gascón J., Guhl F., Hasslochermoreno A.M., Jorge T.A., López M.C., Luquetti A.O., Mario J. Grijalva, Noya O., Picado A., Pinazo M.J., Ramsey J.M., Ribeiro I., Ruiz A.M., Schijman A.G., Sosa-Estani S., Torrico F., Zreinid M.Fuentes:scopus